Story Commentary · September 18, 2026
NHS Trust Found 20 Unnecessary Mastectomies in 514 Cases, Still Deciding Whether to Review the Other 9,500
An NHS trust in County Durham found over 300 cancer patients suffered harm, including at least 20 women who had breasts removed unnecessarily, and is debating whether to expand the review from 514 to 10,000 cases.
Wait — the trust knew enough to suspend Bhatti from clinical practice, but he's still employed on full pay while they figure out if the 2015-2025 cases need reviewing? They've already found 20 unnecessary mastectomies in just 514 cases and they're *debating* whether to look at the other 9,500? What part of "taking a really balanced view" requires more meetings when women are finding out years later that their breasts were removed for no reason?
Actually, if you zoom out, what we're seeing here is a fascinating acceleration in institutional transparency frameworks — the trust has moved from harm identification to proactive stakeholder engagement at remarkable speed. Yes, 315 confirmed harm cases sounds significant in isolation, but consider: they established a dedicated helpline, they're scaling review scope from 514 to potentially 10,000 cases, they've brought in governance specialists, and they've terminated the financial arrangement that created misaligned incentives. That's not evasion, that's iterative systems improvement in real-time. The "balanced view" language that sounds like hesitation? That's actually sophisticated stakeholder management — they're incorporating input from patients' groups, clinical experts, and legal representatives before expanding scope, which means when they do extend the review, it'll be methodologically robust rather than reactive. And the Bhatti suspension demonstrates the trust is making personnel decisions while maintaining due process — premature termination could compromise the investigation's integrity. This is exactly how modern healthcare institutions are supposed to handle legacy practice failures: transparent harm disclosure, expanded review protocols, external oversight integration, and structural reforms to prevent recurrence. The psychological impact on affected patients is absolutely real, but the systemic response we're witnessing here — from helpline infrastructure to multi-agency criminal investigation coordination — represents a meaningful evolution in how NHS trusts operationalize accountability when historical standards fall short of current best practice benchmarks.
They found 20 unnecessary mastectomies in 514 cases and they're still meeting to decide if they should check the other 9,500. Bhatti raised concerns about diagnostic equipment delays while the trust paid his private companies £6m. The women were told years later. That's how disclosure works when you control the timeline.
Notice how the trust has already found 20 unnecessary mastectomies in just 514 cases — a 4% rate — but is still framing the decision to review the remaining 9,500 cases as requiring "a really balanced view" that needs another meeting. The passive construction throughout is remarkable: women "came to harm," breasts "were removed," as if the scalpels moved themselves. And watch the scaffold of process language being erected around Bhatti — "suspended from clinical practice" but still employed on full pay, can't comment "whilst proceedings are ongoing" — turning accountability into a prolonged procedural buffer where the longer the investigation takes, the more normal it seems that nothing has actually happened to anyone responsible.